Paper36367181
Anticancer effects and mechanisms of astragaloside‑IV (Review).
Zhou L and 10 others. Oncol Rep, 2023. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Anticancer effects and mechanisms of astragaloside‑IV (Review). Papers, record 36367181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36367181
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phosphatidylinositol 3-Kinases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Animals | |
| Apoptosis | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Glycogen Synthase Kinase 3 beta | |
| NF-kappa B | |
| Toll-Like Receptor 4 | |
| TOR Serine-Threonine Kinases | |
| Saponins | |
| Triterpenes |
Source PubMed
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31981573 | Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway. | Chem Biol Interact | 2020 | https://conductscience.org/library/papers/31981573 | PubMed |
| 2 | 28112375 | Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. | Oncol Rep | 2017 | https://conductscience.org/library/papers/28112375 | PubMed |
| 3 | 28179291 | Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma. | Anticancer Res | 2017 | https://conductscience.org/library/papers/28179291 | PubMed |
| 4 | 31502185 | Ethnopharmacology, Phytochemistry, Pharmacology, Toxicology and Clinical Applications of Radix Astragali. | Chin J Integr Med | 2021 | https://conductscience.org/library/papers/31502185 | PubMed |
| 5 | 35164321 | Advances in Chemical Composition, Extraction Techniques, Analytical Methods, and Biological Activity of Astragali Radix. | Molecules | 2022 | https://conductscience.org/library/papers/35164321 | PubMed |
| 6 | 30953514 | CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30953514 | PubMed |
| 7 | 25407722 | A review of recent research progress on the astragalus genus. | Molecules | 2014 | https://conductscience.org/library/papers/25407722 | PubMed |
| 8 | 25895919 | The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics. | Cancer Discov | 2015 | https://conductscience.org/library/papers/25895919 | PubMed |
| 9 | 14676209 | Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14676209 | PubMed |
| 10 | 25756512 | PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism. | Cancer Biol Ther | 2015 | https://conductscience.org/library/papers/25756512 | PubMed |
| 11 | 28281965 | Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3. | Oncol Res | 2016 | https://conductscience.org/library/papers/28281965 | PubMed |
| 12 | 35422920 | Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/35422920 | PubMed |
| 13 | 24343578 | Autophagy regulation by nutrient signaling. | Cell Res | 2014 | https://conductscience.org/library/papers/24343578 | PubMed |
| 14 | 19619488 | Wnt/beta-catenin signaling: components, mechanisms, and diseases. | Dev Cell | 2009 | https://conductscience.org/library/papers/19619488 | PubMed |
| 15 | 26621196 | Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/26621196 | PubMed |
| 16 | 32256363 | Uncovering the Anticancer Mechanisms of Chinese Herbal Medicine Formulas: Therapeutic Alternatives for Liver Cancer. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32256363 | PubMed |
| 17 | 31710893 | Antitumor effects of immunity-enhancing traditional Chinese medicine. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/31710893 | PubMed |
| 18 | 31719837 | Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. | Chin Med | 2019 | https://conductscience.org/library/papers/31719837 | PubMed |
| 19 | 30536730 | Astragaloside IV inhibits cell proliferation in vulvar squamous cell carcinoma through the TGF-β/Smad signaling pathway. | Dermatol Ther | 2019 | https://conductscience.org/library/papers/30536730 | PubMed |
| 20 | 31762993 | Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway. | Food Sci Nutr | 2019 | https://conductscience.org/library/papers/31762993 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42740837 | Research Progress of Multicomponent Co-Loaded Nanomedicine Delivery Systems for Tumor Immunotherapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42740837 | PubMed |
| 42445833 | An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42445833 | PubMed |
| 42429050 | Protective effects of Astragaloside IV on various liver diseases: From chemistry to herbal medicines (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42429050 | PubMed |
| 41417465 | Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives. | J Med Chem | 2026 | https://conductscience.org/library/papers/41417465 | PubMed |
| 41235672 | Astragaloside IV promotes the apoptosis of pancreatic cancer cells by activating endoplasmic reticulum stress through the PERK/ATF4/CHOP signaling pathway. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41235672 | PubMed |
| 41235109 | Mechanistic insights into the antitumor effects of astragaloside IV and astragalus polysaccharide in digestive system cancers. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41235109 | PubMed |
| 40999449 | Chinese medicine boosts regenerative medicine in stem cell - based therapy. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40999449 | PubMed |
| 40313623 | NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40313623 | PubMed |
| 40141225 | Th1/Th2 Immune Imbalance in the Spleen of Mice Induced by Hypobaric Hypoxia Stimulation and Therapeutic Intervention of Astragaloside IV. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141225 | PubMed |
| 40104701 | Total Astragalus saponins promote ferroptosis in gastric cancer cells by upregulating SIRT3. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40104701 | PubMed |
| 40055251 | IGF1R activates FOXP3-β-catenin signaling to promote breast cancer development. | Breast Cancer Res Treat | 2025 | https://conductscience.org/library/papers/40055251 | PubMed |
| 39861073 | Phytochemical and Biological Investigations of Crude Extracts of Astragalus pisidicus. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39861073 | PubMed |
| 39081698 | Astragalus membranaceus: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer. | Cancer Manag Res | 2024 | https://conductscience.org/library/papers/39081698 | PubMed |
| 39064966 | Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action. | Molecules | 2024 | https://conductscience.org/library/papers/39064966 | PubMed |
| 38658950 | Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38658950 | PubMed |
| 38361933 | A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer. | Front Immunol | 2024 | https://conductscience.org/library/papers/38361933 | PubMed |
| 38318147 | Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38318147 | PubMed |
| 38305388 | Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice via Targeting Cell Growth, Oxidative Stress, and PTEN/Akt/mTOR Signaling Pathway. | Anticancer Agents Med Chem | 2024 | https://conductscience.org/library/papers/38305388 | PubMed |
| 38289380 | Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation. | Biomol Biomed | 2024 | https://conductscience.org/library/papers/38289380 | PubMed |
| 38193000 | Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness. | Transl Cancer Res | 2023 | https://conductscience.org/library/papers/38193000 | PubMed |
Genes117
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36367181
GET https://conductscience.org/api/papers/v1/36367181/references?page=2